Tower Research Capital LLC (Trc) Ampio Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.08 - $21.0 $321 - $84,420	4,020 New	4,020 $0
Q2 2022 Aug 15, 2022	SELL	$0.16 - $0.47 $3,207 - $9,422	-20,048 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.42 - $0.62 $989 - $1,461	2,357 Added 13.32%	20,048 $9,000
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.71 $5,593 - $17,081	9,989 Added 129.69%	17,691 $10,000
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.8 $4,791 - $7,128	-3,960 Reduced 33.96%	7,702 $13,000
Q2 2021 Aug 16, 2021	SELL	$1.56 - $1.98 $26,924 - $34,172	-17,259 Reduced 59.68%	11,662 $19,000
Q1 2021 May 17, 2021	BUY	$1.36 - $2.49 $5,580 - $10,216	4,103 Added 16.53%	28,921 $49,000
Q4 2020 Feb 16, 2021	BUY	$0.75 - $2.76 $18,613 - $68,497	24,818 New	24,818 $39,000
Q3 2020 Nov 16, 2020	SELL	$0.61 - $1.17 $2,543 - $4,878	-4,170 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.47 - $0.72 $313 - $479	666 Added 19.01%	4,170 $3,000
Q1 2020 May 15, 2020	SELL	$0.36 - $0.74 $6,482 - $13,325	-18,007 Reduced 83.71%	3,504 $1,000
Q4 2019 Feb 07, 2020	BUY	$0.35 - $0.58 $6,272 - $10,393	17,920 Added 499.03%	21,511 $13,000
Q3 2019 Nov 05, 2019	BUY	$0.38 - $0.52 $1,364 - $1,867	3,591 New	3,591 $2,000
Q2 2019 Aug 13, 2019	SELL	$0.39 - $0.7 $2,274 - $4,081	-5,831 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$0.43 - $0.68 $3,186 - $5,039	-7,411 Reduced 55.97%	5,831 $3,000
Q4 2018 Feb 14, 2019	BUY	$0.39 - $0.7 $5,164 - $9,269	13,242 New	13,242 $5,000
Q3 2018 Nov 13, 2018	SELL	$0.44 - $3.02 $2,804 - $19,246	-6,373 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$1.66 - $3.82 $10,579 - $24,344	6,373 New	6,373 $14,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.